Ibrutinib use, treatment duration, and concomitant medications in Australian patients with relapsed or refractory chronic lymphocytic leukaemia. (14th June 2022)

Record Type:: Journal Article
Title:: Ibrutinib use, treatment duration, and concomitant medications in Australian patients with relapsed or refractory chronic lymphocytic leukaemia. (14th June 2022)
Main Title:: Ibrutinib use, treatment duration, and concomitant medications in Australian patients with relapsed or refractory chronic lymphocytic leukaemia
Authors:: Mulligan, Stephen P.
Opat, Stephen
Marlton, Paula
Kuss, Bryone
Gerungan, Poppy
Puig, Andrea
McGeachie, Marija
Tam, Constantine S.
Abstract:
Is Part Of:: British journal of haematology. Volume 198:Number 4(2022)
Journal:: British journal of haematology
Issue:: Volume 198:Number 4(2022)
Issue Display:: Volume 198, Issue 4 (2022)
Year:: 2022
Volume:: 198
Issue:: 4
Issue Sort Value:: 2022-0198-0004-0000
Page Start:: 790
Page End:: 793
Publication Date:: 2022-06-14
Subjects:: Hematology -- Periodicals
Blood -- Diseases -- Periodicals
616.15
Journal URLs:: http://www.blacksci.co.uk/%7Ecgilib/jnlpage.bin?Journal=bjh&File=bjh&Page=aims ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1365-2141 ↗
http://onlinelibrary.wiley.com/ ↗
DOI:: 10.1111/bjh.18306 ↗
Languages:: English
ISSNs:: 0007-1048
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 2309.000000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:: 23011.xml